Skip to main navigation
Skip to search
Skip to main content
Sort by:
Keyphrases
Bone Formation
100%
Sclerostin
72%
MicroRNA
63%
Osteoclast
53%
Bone Loss
50%
Exosomal
48%
Skeletal muscle
48%
Hydroxysteroid Dehydrogenase
48%
Mechanical Loading
30%
Bone Metabolism
29%
Osteoclastogenesis
28%
Inflammatory Response
28%
Type I Inhibitor
27%
Cardiovascular Risk
27%
Aging
27%
Bone Remodeling
27%
Drug Development
26%
Molecular Communication
24%
Osteoblast
24%
MiR-206
24%
Structure Diversity
24%
Genetically Engineered Mice
24%
Argonaute
24%
Bone Phenotype
24%
Diet-induced
24%
Osteoblastic
24%
Obesity
24%
Direct Isolation
24%
Rapid Protocol
24%
Cardiovascular Protective
24%
Aptamer Targeting
24%
Hepatokine
24%
Clinical Aspects
24%
Osteokines
24%
Muscle Atrophy
24%
Protective Behavior
24%
Myokines
24%
High-fat Diet
24%
Osteoprogenitor Cells
24%
Drug Discovery
24%
ApoER2
24%
Long Non-coding RNA (LncRNA)
24%
Migration Inhibitory Factor
24%
Targeted Inhibition
24%
Virtual Screening
24%
Metabolic Disease
24%
Screening Model
24%
Chemical Structure
24%
Chondrocytes
24%
Osteoarthritis Progression
24%
Mouse Bone Marrow
24%
Liver
24%
Osteogenesis Imperfecta
24%
Cathepsin K
24%
MiR-214
24%
Therapeutic Aptamers
24%
ApoE KO Mice
17%
Cardiovascular System
17%
Activating Transcription Factor 4 (ATF4)
16%
Small Molecules
16%
TRAF3
16%
Osteoblastic Bone Formation
14%
Osteoarthritis
13%
Protein Expression
12%
Small Molecule Targeting
12%
Binding Protein
12%
Myostatin
12%
COL1A2
12%
Exosomes
11%
Male Mice
10%
Metabolic Disorders
10%
MicroRNA-21 (miR-21)
9%
Isoproterenol
9%
Osteoclastic
9%
Chronic Variable Stress
9%
Bone Mass
9%
Aged Mice
8%
Small Interfering RNA (siRNA)
8%
Postmenopausal Osteoporosis
8%
Candidate Small Molecules
8%
Osteoclast Activity
8%
Protective Effect
7%
Aortic Aneurysm
7%
Aptamer
7%
Glucocorticoid Signaling
6%
Glucose Handling
6%
Endocrine Glands
6%
Osteoblastogenesis
6%
Follistatin
6%
Osteoglycin
6%
Interleukin-15 (IL-15)
6%
Interleukin-7 (IL-7)
6%
Insulin-like
6%
Irisin
6%
Interleukin
6%
Decorin
6%
Interleukin-6
6%
Growth Factors
6%
PGC-1
6%
Recent Advances
6%
Cell-cell Communication
5%
Angiotensin II Infusion
5%
Cathepsin K Inhibition
5%
Odanacatib
5%
Adverse Effects
5%
Knock-in Mouse Model
5%
Human Mesenchymal Stem Cells (hMSCs)
5%
Knockdown
5%
Migration Capacity
5%
Truncation
5%
Sclerostin Antibody
5%
Biochemistry, Genetics and Molecular Biology
Ossification
88%
Bone Remodeling
74%
Sclerostin
48%
Skeletal Muscle
48%
MicroRNA
47%
Osteolysis
34%
Cell Communication
34%
Osteoblast
33%
Osteoclastogenesis
32%
Osteoclast
32%
Bone Mass
30%
Drug Development
26%
Genetically Engineered Mouse Strain
24%
Chondrocyte
24%
Long Noncoding RNA
24%
Liver Metabolism
24%
Myokine
24%
Cathepsin K
24%
Small Molecule
24%
Argonaute
24%
Lipid
24%
Mediator
24%
Nucleic Acid
24%
Messenger RNA
18%
Protein Expression
14%
TRAF3
12%
Myostatin
12%
Binding Protein
12%
Cytokine
12%
Apolipoprotein E Knockout Mouse
10%
C2C12
10%
Knockout Mouse
10%
Isoprenaline
9%
ATF4
9%
Small Interfering RNA
8%
Osteocyte
8%
Bone Development
8%
Metalloprotease Inhibitor
6%
Osteoclast Activity
6%
Interleukin
6%
Interleukin 15
6%
Interleukin 6
6%
Follistatin
6%
Insulin-Like Growth Factor 1
6%
Interleukin 7
6%
Decorin
6%
Genetics
5%
Stem Cell
5%
Macrophage
5%
Medicine and Dentistry
Ossification
56%
Osteolysis
48%
microRNA
28%
Bone Remodeling
24%
Osteoclastogenesis
24%
Osteoclast
24%
Tumor Microenvironment
24%
Long Untranslated RNA
24%
Migration Inhibition Factor
24%
Sclerostin
24%
Skeletal Muscle
24%
High Fat Food
24%
Chondrocyte
24%
Osteoarthritis
24%
Myokine
24%
Osteoprogenitor Cell
24%
Hydroxysteroid Dehydrogenase
24%
Cardiovascular System
24%
Glucocorticoid
17%
Cytokine
12%
Osteoblast
12%
Myostatin
12%
Protein Binding
12%
Cardiovascular System
10%
Metabolic Disorder
10%
Isoprenaline
9%
Small Interfering RNA
8%
Biological Marker
8%
Cell Communication
8%
Nucleic Acid
8%
Treatment Outcome
8%
Therapeutic Target
8%
Lipid
8%
Mediator
8%
Exosome
6%
Interleukin 6
6%
Interleukin 7
6%
Interleukin 15
6%
Interleukin Derivative
6%
Somatomedin C
6%
Decorin
6%
Follistatin
6%
Irisin
6%
Bone Marrow Mesenchymal Stem Cell
5%